Literature DB >> 10201655

The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly.

N L Smith1, B M Psaty, S R Heckbert, R P Tracy, E S Cornell.   

Abstract

Medication inventory is more reliable than self-report in assessing prescription drug use in elderly populations. It is not known how strongly medication inventory reflects actual medication use as measured by serum drug levels. In the Cardiovascular Health Study, medication data were collected annually by study interviewers from medication containers brought to the clinic visit. At the fourth clinic visit, venipuncture was performed under 12-hour fasting conditions. Participants were told to take medications as usual. Based on medication inventory results, we randomly selected 55 users and 55 non-users of four cardiovascular drugs: aspirin, propranolol, hydrochlorothiazide, and digoxin. All 110 blood samples for each of the four drugs were analyzed; cut points were based on detectable levels given laboratory limitations. Kappa statistics (K) tested degree of agreement between medication inventory findings and serum detection. Assays were completed on 400 samples (91%). Agreement for aspirin (n=102) was poor: K=0.16 (95% CI: 0.0-0.32). Agreement for propranolol (n = 98) was fair: K=0.43 (95% CI: 0.27-0.59). Agreement for hydrochlorothiazide (n=100) was good: K=0.62 (95% CI: 0.53-0.91). Agreement for digoxin (n=100) was excellent: K=0.94 (95% CI: 0.74-1.0). For four all drugs, lack of agreement was confined primarily to participants who reported use but did not have detectable levels. Excluding aspirin users, only one non-user (0.7%) had drug detected in serum. The medication inventory is a reasonably sensitive and a fairly reliable method for ascertaining non-aspirin cardiovascular drug use in the elderly even though this method may overestimate use as assessed by serum level.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201655     DOI: 10.1016/s0895-4356(98)00141-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  40 in total

1.  Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Joseph A C Delaney; Mary L Biggs; Richard A Kronmal; Bruce M Psaty
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11-11       Impact factor: 2.890

2.  Patterns and predictors of recovery from exhaustion in older adults: the cardiovascular health study.

Authors:  Heather E Whitson; Stephen Thielke; Paula Diehr; Ann M O'Hare; Paulo H M Chaves; Neil A Zakai; Alice Arnold; Sarwat Chaudhry; Diane Ives; Anne B Newman
Journal:  J Am Geriatr Soc       Date:  2011-02-02       Impact factor: 5.562

3.  Growth Differentiation Factor-15 and Risk of CKD Progression.

Authors:  Viji Nair; Cassianne Robinson-Cohen; Michelle R Smith; Keith A Bellovich; Zeenat Yousuf Bhat; Maria Bobadilla; Frank Brosius; Ian H de Boer; Laurent Essioux; Ivan Formentini; Crystal A Gadegbeku; Debbie Gipson; Jennifer Hawkins; Jonathan Himmelfarb; Bryan Kestenbaum; Matthias Kretzler; Maria Chiara Magnone; Kalyani Perumal; Susan Steigerwalt; Wenjun Ju; Nisha Bansal
Journal:  J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 10.121

4.  Importance of the lipid-related pathways in the association between statins, mortality, and cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Denis Talbot; Joseph A Chris Delaney; Veit Sandfort; David M Herrington; Robyn L McClelland
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-06       Impact factor: 2.890

5.  Testosterone, Dihydrotestosterone, Sex Hormone-Binding Globulin, and Incident Diabetes Among Older Men: The Cardiovascular Health Study.

Authors:  Katherine E Joyce; Mary L Biggs; Luc Djoussé; Joachim H Ix; Jorge R Kizer; David S Siscovick; Molly M Shores; Alvin M Matsumoto; Kenneth J Mukamal
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

6.  Assessment of physical activity in chronic kidney disease.

Authors:  Cassianne Robinson-Cohen; Alyson J Littman; Glen E Duncan; Baback Roshanravan; T Alp Ikizler; Jonathan Himmelfarb; Bryan R Kestenbaum
Journal:  J Ren Nutr       Date:  2012-06-26       Impact factor: 3.655

7.  H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study.

Authors:  Peter J Leary; R Graham Barr; David A Bluemke; Michael R Bristow; Richard A Kronmal; Joao A Lima; David D Ralph; Corey E Ventetuolo; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2014-11

8.  Physical activity and change in estimated GFR among persons with CKD.

Authors:  Cassianne Robinson-Cohen; Alyson J Littman; Glen E Duncan; Noel S Weiss; Michael C Sachs; John Ruzinski; John Kundzins; Denise Rock; Ian H de Boer; T Alp Ikizler; Jonathan Himmelfarb; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

9.  Racial and ethnic disparities in cardiovascular medication use among older adults in the United States.

Authors:  Dima M Qato; Stacy Tessler Lindau; Rena M Conti; L Philip Schumm; G Caleb Alexander
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

10.  Metabolic Clusters and Outcomes in Older Adults: The Cardiovascular Health Study.

Authors:  Kenneth J Mukamal; David S Siscovick; Ian H de Boer; Joachim H Ix; Jorge R Kizer; Luc Djoussé; Annette L Fitzpatrick; Russell P Tracy; Edward J Boyko; Steven E Kahn; Alice M Arnold
Journal:  J Am Geriatr Soc       Date:  2018-02       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.